Validity of Headache Disability Index

August 3, 2022 updated by: Ozlem Ulger, Hacettepe University

Validity and Reliability of the Turkish Version of The Henry Ford Hospital Headache Disability Index (HDI) in Patients With Cervicogenic Headache

The aim of our study is to investigate the Turkish validity and reliability of The Henry Ford Hospital Headache Disability Questionnaire (HDI), which has not been previously studied in a Turkish version for any headache type in patients with cervicogenic headache.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Headache is a health problem that is reported to occur in 66% of the global population, reducing both quality of life and work productivity. The most common type is tension headache with a prevalence of 38%, followed by migraine headaches with 10%. The incidence of cervicogenic ligament pain has been shown to be between 2.5 and 4.1%. It has been reported that although the prevalence of cervicogenic headache is low compared to tension-type headache and migraine, it affects the quality of life in patients similarly.he International Headache Society has defined cervicogenic headache as pain felt in at least one area of the face or head that radiates from a source in the neck. The most common clinical picture of cervicogenic headache is neck pain, which is usually unilateral and may radiate from the occipital region to the orbit. It has been suggested that neck pain and headache are common comorbidities. Cote et al. reported that headache complaint is 10 times more common in people with neck pain than in people without neck pain.It has been reported that an average of 60-80% of individuals suffering from chronic neck pain have headache problems. C.The validity and reliability studies of the questionnaire on headache in Turkey were generally conducted in patients with migraine. Dikmen et al. performed the Turkish validity and reliability study of the Headache Impact Test-6 (Headache Impact Test-6) questionnaire in patients with migraine. Ertaş et al. published the Turkish version of the Migraine Disability (MIDAS) Questionnaire in the same patient group. However, we could not find a Turkish validity and reliability study of a questionnaire in patients with cervicogenic headache in our country.

The Henry Ford Hospital Headache Disability Questionnaire (HDI), developed by Jacobson et al. in 1994, is a 25-item questionnaire that examines the effects of headache on daily life. This questionnaire has a two-factor structure emotionally and functionally. Scoring (No: 0, Sometimes:2, Yes:4) varies between 0 and 100. The higher the score, the more headache disability.

Study Type

Observational

Enrollment (Anticipated)

250

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Ankara, Turkey, 06510
        • Hasan Erkan Kilinç

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The study population will consist of individuals with cervicogenic headache.

Description

Inclusion Criteria:

  • Getting over 4 points from the Neck Disability Index
  • According to the 3rd edition of the International Headache Disorders Classification System (International Headache Disorders Classification 3rd edition),having at least two of the following parameters, Development of headache temporally related to the onset of cervical problems Significant reduction of headache in parallel with the improvement of cervical problems Variation in headache severity with cervical region movements Decreased range of motion in the cervical region in addition to headache

Exclusion Criteria:

  • Being diagnosed by a neurologist from any of the diagnoses of migraine, cluster headache syndrome, tension headache, chronic post-traumatic headache, drug-induced headache (ICD Diagnostic Codes).
  • Having a history of any neurological or systemic disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Individuals with headache
Individuals with headaches caused by neck problems
Headache Disabilty Index (HDI) will be applied.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Headache Disability Index (HDI)
Time Frame: 15 minutes
Headache Disability Index evaluates the effects of headache on quality of life and disability.
15 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Dilara Onan, MSc, Hacettepe University
  • Study Director: Ozlem Ulger, Hacettepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2022

Primary Completion (Anticipated)

October 1, 2022

Study Completion (Anticipated)

November 1, 2022

Study Registration Dates

First Submitted

May 11, 2022

First Submitted That Met QC Criteria

May 11, 2022

First Posted (Actual)

May 17, 2022

Study Record Updates

Last Update Posted (Actual)

August 4, 2022

Last Update Submitted That Met QC Criteria

August 3, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GO 22/670

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neck Pain

Clinical Trials on Survey Study

Subscribe